In CKD, multiple studies have reported an increase in KYN metabolites [7, 88], behind of which is most likely chronic inflammation, as inflammatory cytokines (such as IFN-γ, TNF-α) activate IDO, the rate-limiting enzyme of KYN synthesis [95]. This evidence concerns the gene IFNG and chronic kidney disease.